Bifidobacterium infantis
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- India
- Brand name
- APEX BIOTECHNOL
- Payment Terms
- T/T
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- bifidobacterium infantis
- Category
- Health Care Supplement
APEX BIOTECHNOL
- Verified Certificate
-
6
Product name | Bifidobacterium infantis | Certification | - |
---|---|---|---|
Category | Health Care Supplement | Ingredients | - |
Keyword | bifidobacterium infantis | Unit Size | - |
Brand name | APEX BIOTECHNOL | Unit Weigh | 25 kg |
origin | India | Stock | - |
Supply type | - | HS code | - |
Product Information
Bifidobacterium infantis
Bifidobacterium infantis is the main friendly intestinal bacteria in breast-fed infants. It is able to outgrow potentially pathogenic organisms and has a role in reducing enteric upsets in infants. Bifidobacterium infantis is a specific inhabitant of the large intestine (colon) where it can be found at high concentrations in infants. It is predominant in the feces of breast-fed infants. Like other bifidobacteria species, this organism produces acids that may retard the colonization of the colon by certain foreign or harmful bacteria. Research suggests that the presence of Bifidobacterium infantis in the colon helps reduce the incidence of infantile diarrhea.
Benefits of Bifidobacterium infantis
- Helps ease symptoms of Irritable Bowel Syndrome, diarrhea & Inflammatory Bowel Disease
- In babies and infants, establishes infant microflora, reduces death among very low birth weight infants and increases immunity
- Produces lactic and acetic acids that lower the intestinal pH and further inhibit the undesirable bacteria
- Assists in the absorption of calcium and other vitamins and minerals
- Prevention of side-effects of oral antibiotic therapy
- Enhances immune system
Specifications for Bifidobacterium infantis
Description | Cream to brown coloured powder with characteristic odour |
Identification | Gram positive rods |
Water activity (aW) | Not more than 1.0 |
Standard concentration | 20/50/100 Billion cfu/g |
Pathogens: Escherichia coli Salmonella species Staphylococcus aureus Pseudomonas aeruginosa | Should be absent/10g Should be absent/10g Should be absent/g Should be absent/g |
Yeast & Mould Count | Not more than 100 cfu/g |
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- PRABHAT SINGH
- Address
- PLOT NO.303 ABHAYPUR INDUSTRIAL AREA PHASE 1 PANCHKULA
- Product Category
- Herbal Medicine
- Year Established
- 2015
- No. of Total Employees
- 1-50
- Company introduction
-
<p>
Apex Biotechnol is an ISO 9001:2015, HACCP and a WHO-GMP certified company. We are working in the area of development of disease specific Herbal Extract and Enzymes solutions. With an unparalleled and unique combination of technical know-how, skilled resources and quality manufacturing, to open up exciting new avenues and offer products that surpass global standards. Apex Biotechnol's quality is ratified by its exports to USA, Europe, Japan, South Africa, Australia, etc. The company with its strong technical and marketing teams, extends unparalleled customer service and builds strong relationships.
We are a quality system for our manufacturing unit which makes us pioneers in providing better quality phytoextract product to our clients for other product requirements. Quality agreement and other processes which are a requirement for a smooth momentum of a manufacturing facility are maintained and complied. The research and development unit in our facility are utilized to test the product safety. Our suppliers of raw material also follow the Ethical code of conduct that are laid down by the FDA congruently produce an effective cutting edge finished product.
The guidance that we follow describes our current thinking on defining, establishing, and x-x-documenting the responsibilities that we lay on our suppliers and third party involved in the manufacturing of drugs with the subject to Current Good Manufacturing Practice (CGMP). In particular, we lay guidelines in the product manufacturing and describe how parties that are involved in the facility of preparing of drugs can follow and utilize Quality Agreements to delineate the responsibilities and assure drug quality, safety, and efficacy to the clients.
- Main Markets
-
Germany
Hong Kong(China)
Indonesia
North Korea
Russia
Singapore
South Korea
Switzerland
Thailand
Uzbekistan
- Factory Information
-
APEX BIOTECHNOL
- Main Product